Dhanwantaram Kashayam: Benefits, Evidence & Safety
TL;DR
Dhanwantaram Kashayam is a classical Ayurvedic polyherbal decoction of about 40 herbs including Bala, Dashamoola, Ashwagandha and Shatavari, traditionally used for Vata disorders, low back ache and postnatal care. Modern research is limited to rat and cell studies showing antioxidant and blood-sugar effects. No human trials exist.
(47 words. Sources: J Diabetes Metab Disord 2020; NCCIH.)
What it is
Dhanwantaram Kashayam (also spelled Dhanwantharam / Dhanvantaram Kashayam) is a classical Ayurvedic polyherbal decoction attributed to the Ashtanga Hridayam lineage, "consists of 40 herbal ingredients" and is taken as a water decoction (Renganathan & Pillai, J Diabetes Metab Disord 2020) (PMID 33553031).
Its traditional ingredient list comprises roughly 40 substances in equal parts: Bala root (Sida cordifolia), barley (Yava), horse gram (Kulattha), the ten Dashamoola roots (Bilva, Agnimantha, Shyonaka, Kashmarya, Patala, Shalaparni, Prishnaparni, Brihati, Kantakari, Gokshura), plus about three dozen further herbs, including Manjishta, Ashwagandha, Shatavari, Triphala fruits, Sariva, Kushta, Punarnava and Ela, along with rock salt (classical Ayurvedic reference aggregator, Tier 3). Commercial compositions and regional variants may differ, so labels should always be checked.
Note: Dhanwantaram Kashayam (the oral decoction described here) is a different product from Dhanwantaram Taila (the medicated oil used externally): the two are frequently confused and are not interchangeable.
Traditional use
In classical Ayurvedic practice, Dhanwantaram Kashayam is indicated for vata diseases, including low back ache, arthritis-like joint pain, numbness and swelling, as well as for post-natal care of the mother, gynaecological conditions, and general weakness. The modern research paper notes its traditional use "as a growth stimulant in children and for nerve regeneration" (PMC 7843830; classical aggregator, Tier 3). These are traditional indications, not evidence of efficacy.
What modern research says
Antidiabetic and antioxidant effects in diabetic rats, 2020
The strongest published study is a 2020 animal trial: 48 male Wistar rats with streptozotocin-induced diabetes received Dhanwantharam Kashayam at 1, 1.5 or 2 ml/kg twice daily for 21 days (the 1.5 ml/kg dose was selected as a human-equivalent dose). Treated rats showed a dose-dependent fall in fasting blood glucose (17%, 54% and 76% reductions respectively), increased antioxidant markers (vitamins C and E, reduced glutathione) and reduced oxidative-stress markers (malondialdehyde, glycosylated haemoglobin, HOMA-IR) versus untreated diabetic rats (Renganathan & Pillai, J Diabetes Metab Disord 2020) (animal study, PMID 33553031). This is a rat finding: it is not evidence that the decoction treats diabetes in humans.
Stem-cell proliferation in the laboratory
An in-vitro study reported that a synthetic formulation of Dhanwantharam Kashaya enhanced proliferation and viability of Wharton's-jelly mesenchymal stem cells while retaining the stemness markers CD73 and CD90, without affecting non-stem control cells (Reghu et al., PMC 2019) (laboratory study). This is a cell-culture finding; it does not prove nerve regeneration or tissue repair in patients.
Phytochemical profile
A phytochemical analysis reported high phenolic, flavonoid and tannin content in the decoction with in-vitro antioxidant activity (DPPH and related assays), consistent with its multi-herb composition (Nandakumar et al., pharmacognosy study) (laboratory study).
Bottom line: the evidence is preclinical: animal and cell-culture studies suggest antioxidant and metabolic effects, but no human clinical trials of Dhanwantaram Kashayam exist, so its efficacy for back pain, arthritis, postnatal recovery or diabetes in people is unproven.
Safety & contraindications
- Herbal-only formulation. Dhanwantaram Kashayam contains no metals or minerals: only herbs and rock salt. However, no human safety trials exist; the available safety-relevant data come from short-term animal dosing.
- Pregnancy and the postnatal period: the formula is traditionally used in postnatal care, but there are no controlled human safety data for pregnancy, breastfeeding or the postnatal period. Use only under the supervision of a qualified practitioner: especially after childbirth or when nursing.
- Children: traditional sources describe use in children as a growth stimulant, but no pediatric trial data exist; practitioner supervision is essential.
- Diabetes: the rat study does not justify using the decoction for diabetes: do not adjust or stop diabetes medicines without medical guidance.
- Interactions: none established; tell your healthcare provider about all Ayurvedic products you use, as NCCIH advises (NCCIH: Ayurvedic Medicine In Depth).
- Not interchangeable with Dhanwantaram Taila (oil): the external oil and the oral decoction are different products with different uses.
FAQs
What is Dhanwantaram Kashayam made of?
About 40 ingredients in equal parts, including Bala root, barley, horse gram, the ten Dashamoola roots, Manjishta, Ashwagandha, Shatavari, Triphala fruits, Sariva, Kushta, Punarnava, cardamom and rock salt. Commercial compositions may vary by manufacturer (classical aggregator, Tier 3).
What is it traditionally used for?
Classical sources indicate it for Vata disorders, low back ache, arthritis-like joint pain, numbness and swelling, as well as post-natal care of the mother and gynaecological conditions. These are traditional indications, not clinically proven effects (PMC 7843830).
Does research show it helps back pain or arthritis?
No human trials exist. A rat study of the decoction in diabetic rats showed antioxidant and blood-sugar effects, and a cell study showed stem-cell proliferation: neither tests back pain or arthritis in people. Efficacy is unproven (PMC 7843830).
What did the diabetes rat study find?
In 48 diabetic rats treated for 21 days, the decoction lowered fasting blood glucose dose-dependently (up to 76% at the highest dose) and improved antioxidant markers. This is an animal finding and is not evidence the decoction treats human diabetes (Renganathan & Pillai 2020).
Is it safe to use after childbirth?
It is traditionally used in postnatal care, but no controlled human safety data exist for the postnatal or breastfeeding period. Given the complex ~40-ingredient formula, use only under the supervision of a qualified practitioner: never self-medicate after childbirth (NCCIH).
Are there side effects?
No human safety trials have been published, so the side-effect profile in people is unknown. The animal studies reported no adverse effects at the tested doses, but that does not establish safety in humans, pregnancy or children (PMC 7843830).
Sources
Tier 1 (Ayush/CCRAS, pharmacopoeial, peer-reviewed journals):
- Renganathan R, Pillai SS. "Effect of Dhanwantharam Kashayam on Streptozotocin Induced Diabetic Wistar Rats." J Diabetes Metab Disord. 2020;19:1413–1419. PMID: 33553031 — PMC · PMC7843830
- Reghu S et al. "A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells." Stem Cell Res Ther (PMC). 2019 — PMC · PMC6495558
- Nandakumar K et al. "Phytochemical evaluation of Dhanwantaram Kashayam." (pharmacognosy laboratory study) — bibliomed.org
Tier 2 (NHS/NCCIH — safety):
- "Ayurvedic Medicine: In Depth." National Center for Complementary and Integrative Health (NCCIH) — NCCIH
Tier 3 (classical aggregators, labeled as such):
- Dhanwantharam Kashayam — ingredients, classical references and traditional indications (classical Ayurvedic reference aggregator) — thepharmacylife.com
Related herbs
- [Ashwagandha](/learn/herbs/ashwagandha)
- [Shatavari](/learn/herbs/shatavari)
- [Triphala Churna](/learn/herbs/triphala-churna)
Disclaimer
This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation. This is especially important if you are pregnant, breastfeeding, managing a medical condition (including diabetes), or taking prescription medicines.